News

Rheonova participated to CPLF 2022

Rheonova participated to CPLF 2022

Rheonova was present at the Congrès de Pneumologie de Langue Française 2022 in Lille where we presented our latest work on bronchial mucus heterogeinity: micro- and macro-rheology study Abstract In lung muco-obstructive diseases, such as cystic fibrosis, chronic...

read more
Rheonova participated at ECFS basic Science 2022

Rheonova participated at ECFS basic Science 2022

Rheonova was present at the ECFS basic science 2022 at Albufeira. Our PhD student Lydia ESTEBAN ENJUTO presented her work on cystic fibrosis sputum handling for rheology. Muco-obstructive diseases, including cystic fibrosis, COPD or severe asthma feature an alteration...

read more
Happy New Year 2022!

Happy New Year 2022!

Rheonova wishes you happy new year 2022!this past year have been rich, challenging and exciting, here is a small preview!

read more
Rheomuco CE marking funding

Rheomuco CE marking funding

Rheonova is supported by the Auvergne Rhône-Alpes region to ensure compliance with the new European regulation for CE marking of our medical device Rheomuco and the associated quality management system. The region, in collaboration with the Agency, Lyonbiopole and...

read more
Rheonova granted the first regional PSPC

Rheonova granted the first regional PSPC

We are happy to announce that Rheonova, in collaboration with Cedrat Technologies and the laboratories TIMA and LRP, have been granted the regional PSPC for the project MucoPiezoRheo. This project aims to develop a medical device for personalized diagnosis and...

read more